RASSF6 and adenocarcinoma: 67.4% (35/52) samples detected lower expression of RASSF6 in adenocarcinoma than adjacent normal tissue, 28.9% (15/52) samples showed no difference and only 3.8% (2/52) samples showed higher expression in adenocarcinoma (Supplementary Table S1).